Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/jcm3030795 http://scihub22266oqcxt.onion/10.3390/jcm3030795 C4449658!4449658!26237478     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Clin+Med 2014 ; 3 (3): 795-808 Nephropedia Template TP {{tp|p=26237478|t=2014. Limitations of Aneuploidy and Anomaly Detection in the Obese Patient |pdf=|usr=}}{{26237478}} gab.com Text Limitations of Aneuploidy and Anomaly Detection in the Obese Patient JO: J Clin Med http://www.kidney.de/pget.php?&tw=1&pmid=26237478 #FOAvip Obesity is a worldwide epidemic and can have a profound effect on pregnancy risks. Obese patients tend to be older and are at increased risk for structural fetal anomalies and aneuploidy, making screening options critically important for these women. Failure rates for first-trimester nuchal translucency (NT) screening increase with obesity, while the ability to detect soft-markers declines, limiting ultrasound-based screening options. Obesity also decreases the chances of completing the anatomy survey and increases the residual risk of undetected anomalies. Additionally, non-invasive prenatal testing (NIPT) is less likely to provide an informative result in obese patients. Understanding the limitations and diagnostic accuracy of aneuploidy and anomaly screening in obese patients can help guide clinicians in counseling patients on the screening options. Twit Text FOAVip Limitations of Aneuploidy and Anomaly Detection in the Obese Patient ????J Clin Med http://www.kidney.de/pget.php?&tw=1&pmid=26237478 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26237478 #FOAvip English Wikipedia <ref>{{Cite pmid|26237478}}</ref> Limitations of Aneuploidy and Anomaly Detection in the Obese Patient #MMPMID26237478 Zozzaro-Smith P; Gray LM; Bacak SJ; Thornburg LL J Clin Med 2014[Sep]; 3 (3): 795-808 PMID26237478show ga Obesity is a worldwide epidemic and can have a profound effect on pregnancy risks. Obese patients tend to be older and are at increased risk for structural fetal anomalies and aneuploidy, making screening options critically important for these women. Failure rates for first-trimester nuchal translucency (NT) screening increase with obesity, while the ability to detect soft-markers declines, limiting ultrasound-based screening options. Obesity also decreases the chances of completing the anatomy survey and increases the residual risk of undetected anomalies. Additionally, non-invasive prenatal testing (NIPT) is less likely to provide an informative result in obese patients. Understanding the limitations and diagnostic accuracy of aneuploidy and anomaly screening in obese patients can help guide clinicians in counseling patients on the screening options. äLimitations of Aneuploidy and Anomaly Detection in the Obese Patient (epmc).pdf DeepDyve Pubget Overpricing